Evidence map›Paper›PMID 33215784›Full record

ArticleThe oncologist2021

Predictive Model for Idiopathic Multicentric Castleman Disease Supporting Treatment Decisions.

Xiaosheng Fang, Zhongling Sun, Zijun Y Xu-Monette, Ken H Young

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The oncologist, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiaosheng FangDepartment of Pathology, Hematopathology Division, Duke University Medical Center, Durham, North Carolina, USA.
Zhongling SunDepartment of Neurology, The People's Hospital of Zhaoyuan City, Shandong, People's Republic of China.
Zijun Y Xu-MonetteDepartment of Pathology, Hematopathology Division, Duke University Medical Center, Durham, North Carolina, USA.ORCID 0000-0002-7615-3949
Ken H YoungDepartment of Pathology, Hematopathology Division, Duke University Medical Center, Durham, North Carolina, USA.ORCID 0000-0002-5755-8932

Funding

Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma: Environmental CoR01CA138688 · NCI · UNIVERSITY OF LOUISVILLE · PI LI, YONG · 2009 to 2017
$2.9M
MYC as a Biomarker in Aggressive Non-Hodgkin LymphomaR01CA187415 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI LI, YONG · 2015 to 2019
$2.2M
Genetic and Epigenetic Biomarkers for B-cell LymphomaR01CA233490 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI YOUNG, KEN H. · 2019 to 2023
$1.8M
Deep Sequencing of Small Regulatory RNAs in Diffuse Large B cell LymphomaRC1CA146299 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI XIAO, CHANGCHUN · 2009 to 2010
$1000k
NCI NIH HHS R01 CA138688NCI NIH HHS R01 CA187415NCI NIH HHS R01 CA233490NCI NIH HHS RC1 CA146299
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Castleman DiseaseHumans

Identifiers

PMID33215784
PMCPMC7794201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.